141 related articles for article (PubMed ID: 18408049)
21. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.
Philip J; Gold M; Milner A; Di Iulio J; Miller B; Spruyt O
J Pain Symptom Manage; 2006 Dec; 32(6):541-50. PubMed ID: 17157756
[TBL] [Abstract][Full Text] [Related]
22. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F
Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481
[TBL] [Abstract][Full Text] [Related]
23. Nebulized furosemide for the management of dyspnea: does the evidence support its use?
Newton PJ; Davidson PM; Macdonald P; Ollerton R; Krum H
J Pain Symptom Manage; 2008 Oct; 36(4):424-41. PubMed ID: 18468839
[TBL] [Abstract][Full Text] [Related]
24. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
[TBL] [Abstract][Full Text] [Related]
25. Breathlessness in cancer patients.
Cachia E; Ahmedzai SH
Eur J Cancer; 2008 May; 44(8):1116-23. PubMed ID: 18424030
[TBL] [Abstract][Full Text] [Related]
26. Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.
Shimoyama N; Shimoyama M
J Pain Symptom Manage; 2002 Jan; 23(1):73-6. PubMed ID: 11779672
[TBL] [Abstract][Full Text] [Related]
27. Nebulised furosemide in the palliation of dyspnoea in cancer: a systematic review.
Jeba J; George R; Pease N
BMJ Support Palliat Care; 2014 Jun; 4(2):132-139. PubMed ID: 24644194
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; OroĊska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial.
Hermanns T; Sauermann P; Rufibach K; Frauenfelder T; Sulser T; Strebel RT
Eur Urol; 2009 Sep; 56(3):407-12. PubMed ID: 19375849
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial.
Valderramas SR; Atallah AN
Respir Care; 2009 Mar; 54(3):327-33. PubMed ID: 19245725
[TBL] [Abstract][Full Text] [Related]
31. Does palliative home oxygen improve dyspnoea? A consecutive cohort study.
Currow DC; Agar M; Smith J; Abernethy AP
Palliat Med; 2009 Jun; 23(4):309-16. PubMed ID: 19304806
[TBL] [Abstract][Full Text] [Related]
32. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
Videler WJ; van Drunen CM; Reitsma JB; Fokkens WJ
Rhinology; 2008 Jun; 46(2):92-8. PubMed ID: 18575008
[TBL] [Abstract][Full Text] [Related]
33. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
[TBL] [Abstract][Full Text] [Related]
34. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
35. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.
Young IH; Daviskas E; Keena VA
Thorax; 1989 May; 44(5):387-90. PubMed ID: 2669222
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses.
Hinchcliff KW; Morley PS; Guthrie AJ
J Am Vet Med Assoc; 2009 Jul; 235(1):76-82. PubMed ID: 19566461
[TBL] [Abstract][Full Text] [Related]
37. Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking.
Sandland CJ; Morgan MD; Singh SJ
Respir Med; 2008 Aug; 102(8):1148-52. PubMed ID: 18571914
[TBL] [Abstract][Full Text] [Related]
38. Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure.
Towers KA; Bardsley KA; Macdonald PS
Med J Aust; 2010 Nov; 193(9):555. PubMed ID: 21034394
[No Abstract] [Full Text] [Related]
39. Effect of magnesium and furosemide on bronchial asthma.
Telia A; Tutashvili M; Donguzashvili S; Pirtskhalava N
Georgian Med News; 2005 Nov; (128):55-9. PubMed ID: 16369066
[TBL] [Abstract][Full Text] [Related]
40. Is nebulized saline a placebo in COPD?
Khan SY; O'Driscoll BR
BMC Pulm Med; 2004 Sep; 4():9. PubMed ID: 15458566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
